Dr John Philip Dagirmanjian, MD in Glendale, AZ - Medicare Anesthesiology

Dr John Philip Dagirmanjian, MD is a medicare enrolled "Anesthesiology" physician in Glendale, Arizona. He graduated from medical school in 1988 and has 36 years of diverse experience with area of expertise as Anesthesiology. He is a member of the group practice Anesthesia Partners Of Arizona Llc and his current practice location is 18205 N 51st Ave, Suite 109, Glendale, Arizona. You can reach out to his office (for appointments etc.) via phone at (602) 547-1400.

Dr John Philip Dagirmanjian is licensed to practice in Arizona (license number 27974) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1225017676.

Contact Information

	Dr John Philip Dagirmanjian, MD
	18205 N 51st Ave, Suite 109, Glendale, AZ 85308-1490
	(602) 547-1400
	(602) 547-1401

Physician's Profile

Full Name	Dr John Philip Dagirmanjian
Gender	Male
Speciality	Anesthesiology
Experience	36 Years
Location	18205 N 51st Ave, Glendale, Arizona
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Dr John Philip Dagirmanjian graduated from medical school in 1988

NPI Data:

NPI Number: 1225017676
Provider Enumeration Date: 01/13/2006
Last Update Date: 05/27/2008

Medicare PECOS Information:

PECOS PAC ID: 5092776872
Enrollment ID: I20041025000783

Medical Identifiers

Medical identifiers for Dr John Philip Dagirmanjian such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1225017676	NPI	-	NPPES
759798	Medicaid	AZ
Z75226	Other	AZ	MEDICARE ID

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207L00000X	Anesthesiology	27974 (Arizona)	Primary

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Anesthesia Partners Of Arizona Llc	8628317179	181

News Archive

UTILITY receives FDA approval for Investigational New Drug applications

UTILITY therapeutics Ltd, a pharmaceutical company focused on developing and commercializing antibiotics in the US, today announces that the US Food and Drug Administration has approved the Investigational New Drug applications for mecillinam and pivmecillinam.

Olympus introduces Endo Capsule Software for examining high resolution small bowel images

Olympus, a precision technology leader, creating innovative opto-digital solutions in healthcare, life science and consumer electronics products, today announced the introduction of its improved user-friendly Endo Capsule Software version 1.02A, a customized and comprehensive system for examining high resolution small bowel images.

CHSI enters definitive agreement to acquire WHI for $525 million

Catalyst Health Solutions, Inc. announced that it has entered into a definitive agreement with Walgreen Co. to acquire Walgreens' pharmacy benefit management subsidiary, Walgreens Health Initiatives, Inc., for $525 million in cash.

FDA grants Tolera's TOL101 orphan drug designation for treatment of T1DM

Tolera Therapeutics, Inc., was granted orphan drug status by the United States Food and Drug Administration (FDA) for TOL101 (anti-TCR murine monoclonal antibody, type IgM), for treatment of recent onset immune-mediated Type 1 diabetes mellitus (T1DM). Designation is granted for treatment of patients sixteen years of age and younger with immune-mediated T1DM and preserved pancreatic beta-cell function, commonly referred to as juvenile diabetes.

Research findings could lead to new therapies to correct neurological disorders

Yale University researchers have found that a single molecule not only connects brain cells but also changes how we learn. The findings, reported in the December 9 issue of the journal Neuron, may help researchers discover ways to improve memory and could lead to new therapies to correct neurological disorders.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr John Philip Dagirmanjian allows following entities to bill medicare on his behalf.

Entity Name	Arizona Anesthesia Consultants. Inc.
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1740402940 PECOS PAC ID: 1355239732 Enrollment ID: O20040308000727

News Archive

UTILITY receives FDA approval for Investigational New Drug applications

Olympus introduces Endo Capsule Software for examining high resolution small bowel images

CHSI enters definitive agreement to acquire WHI for $525 million

FDA grants Tolera's TOL101 orphan drug designation for treatment of T1DM

Research findings could lead to new therapies to correct neurological disorders

Entity Name	Anesthesia Partners Of Arizona Llc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1619452901 PECOS PAC ID: 8628317179 Enrollment ID: O20190228001927

UTILITY receives FDA approval for Investigational New Drug applications

Olympus introduces Endo Capsule Software for examining high resolution small bowel images

CHSI enters definitive agreement to acquire WHI for $525 million

FDA grants Tolera's TOL101 orphan drug designation for treatment of T1DM

Research findings could lead to new therapies to correct neurological disorders

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr John Philip Dagirmanjian is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Dr John Philip Dagirmanjian, MD 18205 N 51st Ave, Suite 109, Glendale, AZ 85308-1490 Ph: (602) 547-1400	Dr John Philip Dagirmanjian, MD 18205 N 51st Ave, Suite 109, Glendale, AZ 85308-1490 Ph: (602) 547-1400

News Archive

UTILITY receives FDA approval for Investigational New Drug applications

Olympus introduces Endo Capsule Software for examining high resolution small bowel images

CHSI enters definitive agreement to acquire WHI for $525 million

FDA grants Tolera's TOL101 orphan drug designation for treatment of T1DM

Research findings could lead to new therapies to correct neurological disorders

Anesthesiology Doctors in Glendale, AZ

Dr. Patrick William Hogan, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 7200 W Bell Rd, Ste F101, Glendale, AZ 85308 Phone: 602-795-8700 Fax: 602-795-8701
Dr. Cary J Colter, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 5757 W Thunderbird Rd, Suite W-400, Glendale, AZ 85306 Phone: 602-547-1400 Fax: 602-547-1401
Dr. Kevin Doyle Carter, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 5757 W Thunderbird Rd, Suite W-400, Glendale, AZ 85306 Phone: 602-547-1400 Fax: 602-547-1401
Dr. David S. Higgins, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 5757 W Thunderbird Rd, Suite W-400, Glendale, AZ 85306 Phone: 602-547-1400 Fax: 602-547-1401
Dr. Brian S Page, DO Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 20325 N. 51st Ave, Bld 8 Suite 160, Glendale, AZ 85308 Phone: 623-466-6350 Fax: 602-358-8698
Megan J. Sharpe, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 18205 N 51st Ave Ste 109, Glendale, AZ 85308 Phone: 602-547-1400 Fax: 602-547-1401

Dr John Philip Dagirmanjian, MD - Medicare Anesthesiology in Glendale, AZ

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Group Practice Association

UTILITY receives FDA approval for Investigational New Drug applications

Olympus introduces Endo Capsule Software for examining high resolution small bowel images

CHSI enters definitive agreement to acquire WHI for $525 million

FDA grants Tolera's TOL101 orphan drug designation for treatment of T1DM

Research findings could lead to new therapies to correct neurological disorders

Medicare Reassignments

UTILITY receives FDA approval for Investigational New Drug applications

Olympus introduces Endo Capsule Software for examining high resolution small bowel images

CHSI enters definitive agreement to acquire WHI for $525 million

FDA grants Tolera's TOL101 orphan drug designation for treatment of T1DM

Research findings could lead to new therapies to correct neurological disorders

UTILITY receives FDA approval for Investigational New Drug applications

Olympus introduces Endo Capsule Software for examining high resolution small bowel images

CHSI enters definitive agreement to acquire WHI for $525 million

FDA grants Tolera's TOL101 orphan drug designation for treatment of T1DM

Research findings could lead to new therapies to correct neurological disorders

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

UTILITY receives FDA approval for Investigational New Drug applications

Olympus introduces Endo Capsule Software for examining high resolution small bowel images

CHSI enters definitive agreement to acquire WHI for $525 million

FDA grants Tolera's TOL101 orphan drug designation for treatment of T1DM

Research findings could lead to new therapies to correct neurological disorders

Anesthesiology Doctors in Glendale, AZ